Okamoto I[au] - PubMed

Search results

Items: 1 to 50 of 471

<< First< Prev

Page of 10

Select item 304290111.

Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer.

Kawano Y, Sasaki T, Yamaguchi H, Hirano K, Horiike A, Satouchi M, Hosokawa S, Morinaga R, Komiya K, Inoue K, Fujita Y, Toyozawa R, Kimura T, Takahashi K, Nishikawa K, Kishimoto J, Nakanishi Y, Okamoto I.

Lung Cancer. 2018 Nov;125:136-141. doi: 10.1016/j.lungcan.2018.09.014. Epub 2018 Sep 18.

PMID:: 30429011

Similar articles

Select item 304203462.

Decision-making for people with dementia and advanced kidney disease: a secondary qualitative analysis of interviews from the Conservative Kidney Management Assessment of Practice Patterns Study.

Scott J, Owen-Smith A, Tonkin-Crine S, Rayner H, Roderick P, Okamoto I, Leydon G, Caskey F, Methven S.

BMJ Open. 2018 Nov 12;8(11):e022385. doi: 10.1136/bmjopen-2018-022385.

PMID:: 30420346

Free Article

Similar articles

Select item 303487143.

Radiological Features of Programmed Cell Death-Ligand 2-positive Lung Adenocarcinoma: A Single-institution Retrospective Study.

Takada K, Toyokawa G, Azuma K, Takamori S, Jogo T, Hirai F, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y.

In Vivo. 2018 Nov-Dec;32(6):1541-1550. doi: 10.21873/invivo.11412.

PMID:: 30348714

Similar articles

Select item 302939444.

Pemetrexed and carboplatin combination therapy followed by pemetrexed maintenance in Japanese patients with non-squamous non-small cell lung cancer: A subgroup analysis of elderly patients.

Nogami N, Nishio M, Okamoto I, Enatsu S, Suzukawa K, Takai H, Nakagawa K, Tamura T.

Respir Investig. 2018 Oct 4. pii: S2212-5345(18)30256-9. doi: 10.1016/j.resinv.2018.09.003. [Epub ahead of print]

PMID:: 30293944

Similar articles

Select item 302895755.

Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing.

Iwama E, Sakai K, Azuma K, Harada D, Nosaki K, Hotta K, Nishio M, Kurata T, Fukuhara T, Akamatsu H, Goto K, Shimose T, Kishimoto J, Nakanishi Y, Nishio K, Okamoto I.

Cancer Sci. 2018 Oct 5. doi: 10.1111/cas.13820. [Epub ahead of print]

PMID:: 30289575

Free Article

Similar articles

Select item 302826106.

Structural and functional analysis of miraculin-like protein from Vitis vinifera.

Ohkura SI, Hori M, Saitoh K, Okuzawa T, Okamoto I, Furukawa N, Shimizu-Ibuka A.

Biochim Biophys Acta Proteins Proteom. 2018 Nov;1866(11):1125-1130. doi: 10.1016/j.bbapap.2018.08.009. Epub 2018 Aug 27.

PMID:: 30282610

Similar articles

Select item 302752177.

Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung Cancer.

Takamori S, Takada K, Azuma K, Jogo Y, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Toyokawa G, Hirai F, Tagawa T, Okamoto I, Nakanishi Y, Kawahara A, Akiba J, Oda Y, Maehara Y.

Anticancer Res. 2018 Oct;38(10):5903-5907. doi: 10.21873/anticanres.12934.

PMID:: 30275217

Similar articles

Select item 302752168.

PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer.

Takamori S, Takada K, Toyokawa G, Azuma K, Shimokawa M, Jogo T, Yamada Y, Hirai F, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y.

Anticancer Res. 2018 Oct;38(10):5897-5901. doi: 10.21873/anticanres.12933.

PMID:: 30275216

Similar articles

Select item 302618039.

Prevention of anastomotic leak using an advanced pectoral flap in total pharyngolaryngectomy and free jejunal reconstruction for hypopharyngeal or laryngeal carcinoma.

Kondo T, Tsukahara K, Yoshizawa N, Okamoto I, Motohashi R, Nomoto M, Katsube Y, Yatomi M, Iwasawa T, Hanyu K, Ogawa Y.

Acta Otolaryngol. 2018 Sep 27:1-5. doi: 10.1080/00016489.2018.1492152. [Epub ahead of print]

PMID:: 30261803

Similar articles

Select item 3025561410.

Sensitivity of epidermal growth factor receptor with single or double uncommon mutations to afatinib confirmed by a visual assay.

Kimura S, Tanaka K, Harada T, Liu R, Shibahara D, Kawano Y, Nakanishi Y, Okamoto I.

Cancer Sci. 2018 Nov;109(11):3657-3661. doi: 10.1111/cas.13787. Epub 2018 Sep 25.

PMID:: 30255614

Free PMC Article

Similar articles

Select item 3024085211.

Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset.

Cho BC, Chewaskulyong B, Lee KH, Dechaphunkul A, Sriuranpong V, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cheng Y, Cho EK, Voon PJ, Lee JS, Mann H, Saggese M, Reungwetwattana T, Ramalingam SS, Ohe Y.

J Thorac Oncol. 2018 Sep 18. pii: S1556-0864(18)33091-0. doi: 10.1016/j.jtho.2018.09.004. [Epub ahead of print]

PMID:: 30240852

Similar articles

Select item 3023724612.

Generation of human oogonia from induced pluripotent stem cells in vitro.

Yamashiro C, Sasaki K, Yabuta Y, Kojima Y, Nakamura T, Okamoto I, Yokobayashi S, Murase Y, Ishikura Y, Shirane K, Sasaki H, Yamamoto T, Saitou M.

Science. 2018 Oct 19;362(6412):356-360. doi: 10.1126/science.aat1674. Epub 2018 Sep 20.

PMID:: 30237246

Similar articles

Select item 3021836613.

Combined Immunofluorescence, RNA FISH, and DNA FISH in Preimplantation Mouse Embryos.

Okamoto I.

Methods Mol Biol. 2018;1861:149-159. doi: 10.1007/978-1-4939-8766-5_12.

PMID:: 30218366

Similar articles

Select item 3017574514.

Spontaneous and Direct Transformation of N,O-Diaryl Carbamates into N,N'-Diarylureas.

Yamasaki R, Honjo Y, Ito A, Fukuda K, Okamoto I.

Chem Pharm Bull (Tokyo). 2018;66(9):880-884. doi: 10.1248/cpb.c18-00394.

PMID:: 30175745

Free Article

Similar articles

Select item 3015533115.

Concomitant Extramedullary Plasmacytoma in the Oropharynx and Hypopharyngeal Squamous Cell Carcinoma.

Sato H, Yoshimasu S, Okamoto I, Shimizu A, Katsube Y, Tanaka H, Tsukahara K.

Case Rep Otolaryngol. 2018 Jul 31;2018:1463218. doi: 10.1155/2018/1463218. eCollection 2018.

PMID:: 30155331

Free PMC Article

Similar articles

Select item 3015309716.

CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Reungwetwattana T, Nakagawa K, Cho BC, Cobo M, Cho EK, Bertolini A, Bohnet S, Zhou C, Lee KH, Nogami N, Okamoto I, Leighl N, Hodge R, McKeown A, Brown AP, Rukazenkov Y, Ramalingam SS, Vansteenkiste J.

J Clin Oncol. 2018 Aug 28:JCO2018783118. doi: 10.1200/JCO.2018.78.3118. [Epub ahead of print]

PMID:: 30153097

Similar articles

Select item 3015259417.

Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis.

Ide M, Tanaka K, Sunami S, Asoh T, Maeyama T, Tsuruta N, Nakanishi Y, Okamoto I.

Thorac Cancer. 2018 Nov;9(11):1519-1521. doi: 10.1111/1759-7714.12853. Epub 2018 Aug 28.

PMID:: 30152594

Similar articles

Select item 3012160118.

Reuse of intermittent catheters: a qualitative study of IC users' perspectives.

Avery M, Prieto J, Okamoto I, Cullen S, Clancy B, Moore KN, Macaulay M, Fader M.

BMJ Open. 2018 Aug 17;8(8):e021554. doi: 10.1136/bmjopen-2018-021554.

PMID:: 30121601

Free PMC Article

Similar articles

Select item 3009397119.

Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade.

Tanaka K, Yanagihara T, Ikematsu Y, Inoue H, Ota K, Kashiwagi E, Suzuki K, Hamada N, Takeuchi A, Tatsugami K, Eto M, Ijichi K, Oda Y, Otsubo K, Yoneshima Y, Iwama E, Nakanishi Y, Okamoto I.

Oncotarget. 2018 Jul 17;9(55):30587-30593. doi: 10.18632/oncotarget.25743. eCollection 2018 Jul 17.

PMID:: 30093971

Free PMC Article

Similar articles

Select item 2989820520.

Contributions by MC1R Variants to Melanoma Risk in Males and Females.

Wendt J, Mueller C, Rauscher S, Fae I, Fischer G, Okamoto I.

JAMA Dermatol. 2018 Jul 1;154(7):789-795. doi: 10.1001/jamadermatol.2018.1252.

PMID:: 29898205

Similar articles

Select item 2985033721.

A Case of Septicemia due to Nonocclusive Mesenteric Ischemia Occurring in Induction Chemotherapy.

Tanaka H, Tsukahara K, Okamoto I, Kojima R, Hirasawa K, Sato H.

Case Rep Otolaryngol. 2018 Apr 19;2018:7426819. doi: 10.1155/2018/7426819. eCollection 2018.

PMID:: 29850337

Free PMC Article

Similar articles

Select item 2976474822.

Anticancer drug treatment for advanced lung cancer with interstitial lung disease.

Otsubo K, Okamoto I, Hamada N, Nakanishi Y.

Respir Investig. 2018 Jul;56(4):307-311. doi: 10.1016/j.resinv.2018.03.002. Epub 2018 Apr 13. Review.

PMID:: 29764748

Similar articles

Select item 2974802423.

Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.

Kimura S, Harada T, Ijichi K, Tanaka K, Liu R, Shibahara D, Kawano Y, Otsubo K, Yoneshima Y, Iwama E, Nakanishi Y, Okamoto I.

Lung Cancer. 2018 Jun;120:98-107. doi: 10.1016/j.lungcan.2018.04.005. Epub 2018 Apr 5.

PMID:: 29748024

Similar articles

Select item 2971807324.

CNS response to osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFR-TKI sensitising mutation (EGFRm)-positive advanced non-small cell lung cancer (NSCLC): Data from the FLAURA study.

Vansteenkiste J, Reungwetwattana T, Nakagawa K, Cho BC, Dols MAC, Cho EK, Bertolini A, Bohnet S, Zhou C, Lee KH, Nogami N, Okamoto I, Leighl N, Hodge R, McKeown A, Brown AP, Rukazenkov Y, Ramalingam S.

Ann Oncol. 2017 Nov 1;28(suppl_10). doi: 10.1093/annonc/mdx782. No abstract available.

PMID:: 29718073

Similar articles

Select item 2969787625.

Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial.

Akamatsu H, Katakami N, Okamoto I, Kato T, Kim YH, Imamura F, Shinkai M, Hodge RA, Uchida H, Hida T.

Cancer Sci. 2018 Jun;109(6):1930-1938. doi: 10.1111/cas.13623. Epub 2018 May 31.

PMID:: 29697876

Free PMC Article

Similar articles

Select item 2959691026.

Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non-Small Cell Lung Cancer.

Shibahara D, Tanaka K, Iwama E, Kubo N, Ota K, Azuma K, Harada T, Fujita J, Nakanishi Y, Okamoto I.

J Thorac Oncol. 2018 Jul;13(7):926-937. doi: 10.1016/j.jtho.2018.03.012. Epub 2018 Mar 27.

PMID:: 29596910

Similar articles

Select item 2957200027.

PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements.

Yoneshima Y, Ijichi K, Anai S, Ota K, Otsubo K, Iwama E, Tanaka K, Oda Y, Nakanishi Y, Okamoto I.

Lung Cancer. 2018 Apr;118:36-40. doi: 10.1016/j.lungcan.2018.01.024. Epub 2018 Feb 2.

PMID:: 29572000

Similar articles

Select item 2954991028.

Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.

Akamine T, Takada K, Toyokawa G, Kinoshita F, Matsubara T, Kozuma Y, Haratake N, Takamori S, Hirai F, Tagawa T, Okamoto T, Yoneshima Y, Okamoto I, Shimokawa M, Oda Y, Nakanishi Y, Maehara Y.

Surg Oncol. 2018 Mar;27(1):88-94. doi: 10.1016/j.suronc.2018.01.002. Epub 2018 Jan 9.

PMID:: 29549910

Similar articles

Select item 2952363529.

Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria.

Müller C, Krunic M, Wendt J, von Haeseler A, Okamoto I.

G3 (Bethesda). 2018 May 4;8(5):1475-1480. doi: 10.1534/g3.117.300394.

PMID:: 29523635

Free PMC Article

Similar articles

Select item 2949625030.

Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.

Okamoto I, Morita S, Tashiro N, Imamura F, Inoue A, Seto T, Yamamoto N, Ohe Y, Nakagawa K, Fukuoka M.

Lung Cancer. 2018 Mar;117:14-19. doi: 10.1016/j.lungcan.2018.01.005. Epub 2018 Jan 9.

PMID:: 29496250

Free Article

Similar articles

Select item 2947455831.

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.

Kiura K, Imamura F, Kagamu H, Matsumoto S, Hida T, Nakagawa K, Satouchi M, Okamoto I, Takenoyama M, Fujisaka Y, Kurata T, Ito M, Tokushige K, Hatano B, Nishio M.

Jpn J Clin Oncol. 2018 Apr 1;48(4):367-375. doi: 10.1093/jjco/hyy016.

PMID:: 29474558

Free PMC Article

Similar articles

Select item 2943448332.

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers.

Shimada R, Tsukahara K, Takase S, Okamoto I, Sato H, Katsube Y, Maruyama R, Shimizu A.

Jpn Clin Med. 2018 Jan 29;9:1179670717749231. doi: 10.1177/1179670717749231. eCollection 2018.

PMID:: 29434483

Free PMC Article

Similar articles

Select item 2936336933.

Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer.

Iwama E, Nakanishi Y, Okamoto I.

Expert Rev Anticancer Ther. 2018 Mar;18(3):267-276. doi: 10.1080/14737140.2018.1432356. Epub 2018 Jan 27.

PMID:: 29363369

Similar articles

Select item 2936325034.

Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples.

Kiura K, Yoh K, Katakami N, Nogami N, Kasahara K, Takahashi T, Okamoto I, Cantarini M, Hodge R, Uchida H.

Cancer Sci. 2018 Apr;109(4):1177-1184. doi: 10.1111/cas.13511. Epub 2018 Feb 27.

PMID:: 29363250

Free PMC Article

Similar articles

Select item 2929025135.

Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer.

Tanaka K, Isse K, Fujihira T, Takenoyama M, Saunders L, Bheddah S, Nakanishi Y, Okamoto I.

Lung Cancer. 2018 Jan;115:116-120. doi: 10.1016/j.lungcan.2017.11.018. Epub 2017 Nov 22.

PMID:: 29290251

Similar articles

Select item 2927782336.

Clinical Significance of PD-L1 Expression in Brain Metastases from Non-small Cell Lung Cancer.

Takamori S, Toyokawa G, Okamoto I, Takada K, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Mukae N, Hirai F, Tagawa T, Oda Y, Iwaki T, Iihara K, Nakanishi Y, Maehara Y.

Anticancer Res. 2018 Jan;38(1):553-557.

PMID:: 29277823

Similar articles

Select item 2926965437.

Metastatic Lung Adenocarcinoma Mimicking Meningioma.

Yanagihara T, Seki N, Hiwatashi A, Arimura K, O Suzuki S, Okamoto I.

Intern Med. 2018 Apr 1;57(7):1057-1058. doi: 10.2169/internalmedicine.9472-17. Epub 2017 Dec 21. No abstract available.

PMID:: 29269654

Free PMC Article

Similar articles

Select item 2915135938.

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cho BC, Cheng Y, Cho EK, Voon PJ, Planchard D, Su WC, Gray JE, Lee SM, Hodge R, Marotti M, Rukazenkov Y, Ramalingam SS; FLAURA Investigators.

N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137. Epub 2017 Nov 18.

PMID:: 29151359

Free Article

Similar articles

Select item 2911085339.

CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.

Kawano Y, Iwama E, Tsuchihashi K, Shibahara D, Harada T, Tanaka K, Nagano O, Saya H, Nakanishi Y, Okamoto I.

Lung Cancer. 2017 Nov;113:72-78. doi: 10.1016/j.lungcan.2017.09.008. Epub 2017 Sep 14.

PMID:: 29110853

Similar articles

Select item 2910132140.

Contribution of epigenetic landscapes and transcription factors to X-chromosome reactivation in the inner cell mass.

Borensztein M, Okamoto I, Syx L, Guilbaud G, Picard C, Ancelin K, Galupa R, Diabangouaya P, Servant N, Barillot E, Surani A, Saitou M, Chen CJ, Anastassiadis K, Heard E.

Nat Commun. 2017 Nov 3;8(1):1297. doi: 10.1038/s41467-017-01415-5.

PMID:: 29101321

Free PMC Article

Similar articles

Select item 2908840541.

Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer.

Otsubo K, Seki N, Nakanishi Y, Okamoto I.

Ann Oncol. 2018 Mar 1;29(3):780-781. doi: 10.1093/annonc/mdx700. No abstract available.

PMID:: 29088405

Similar articles

Select item 2906977342.

Visualization and quantitation of epidermal growth factor receptor homodimerization and activation with a proximity ligation assay.

Ota K, Harada T, Otsubo K, Fujii A, Tsuchiya Y, Tanaka K, Okamoto I, Nakanishi Y.

Oncotarget. 2017 Jul 25;8(42):72127-72132. doi: 10.18632/oncotarget.19552. eCollection 2017 Sep 22.

PMID:: 29069773

Free PMC Article

Similar articles

Select item 2905903743.

Prediction of Therapeutic Effect of Chemotherapy for NSCLC Using Dual-Input Perfusion CT Analysis: Comparison among Bevacizumab Treatment, Two-Agent Platinum-based Therapy without Bevacizumab, and Other Non-Bevacizumab Treatment Groups.

Yabuuchi H, Kawanami S, Iwama E, Okamoto I, Kamitani T, Sagiyama K, Yamasaki Y, Honda H.

Radiology. 2018 Feb;286(2):685-695. doi: 10.1148/radiol.2017162204. Epub 2017 Oct 23.

PMID:: 29059037

Similar articles

Select item 2904349644.

Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety Results.

Kato T, Seto T, Nishio M, Goto K, Yamamoto N, Okamoto I, Tao L, Yu W, Khaznadar T, Tajima K, Shibata M, Seki A, Yamamoto N.

Drug Saf. 2018 Feb;41(2):229-237. doi: 10.1007/s40264-017-0596-0.

PMID:: 29043496

Free PMC Article

Similar articles

Select item 2902720945.

Heterogeneous distribution of alectinib in neuroblastoma xenografts revealed by matrix-assisted laser desorption ionization mass spectrometry imaging: a pilot study.

Ryu S, Hayashi M, Aikawa H, Okamoto I, Fujiwara Y, Hamada A.

Br J Pharmacol. 2018 Jan;175(1):29-37. doi: 10.1111/bph.14067. Epub 2017 Nov 6.

PMID:: 29027209

Similar articles

Select item 2897826646.

Parapharyngeal space tumor surgery using a modified cervical-parotid approach.

Okamoto I, Tsukahara K, Sato H.

Acta Otolaryngol. 2018 Feb;138(2):165-169. doi: 10.1080/00016489.2017.1384058. Epub 2017 Oct 5.

PMID:: 28978266

Similar articles

Select item 2897810247.

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non-small cell lung cancer harboring EGFR mutations.

Tanaka K, Nosaki K, Otsubo K, Azuma K, Sakata S, Ouchi H, Morinaga R, Wataya H, Fujii A, Nakagaki N, Tsuruta N, Takeshita M, Iwama E, Harada T, Nakanishi Y, Okamoto I.

Oncotarget. 2017 Jul 12;8(40):68123-68130. doi: 10.18632/oncotarget.19243. eCollection 2017 Sep 15.